Celgene Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Celgene Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4436
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Celgene Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Celgene Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Celgene Corporation (Celgene or ‘the company’) is an integrated biopharmaceutical company that is primarily involved in the research, development and marketing of novel therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. These are marketed under IMNOVID, REVLIMID, THALOMID and VIDAZA, to mention a few. It sells these products through wholesale distributors and specialty pharmacies in the US and its international sales are made directly to hospitals, clinics and retail chains, many of which are government owned. The company operates in the US, Europe and other countries. Celgene is headquartered in Summit, New Jersey, the US.

Scope

- Detailed information on Celgene Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Celgene Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Celgene Corporation including a breakdown and examination of key business segments
- Intelligence on Celgene Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Celgene Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Celgene Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Celgene Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Celgene Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Celgene Corporation: Company Overview 9
Celgene Corporation: Overview and Key Facts 9
Celgene Corporation: Overview 9
Celgene Corporation: Key Facts 9
Celgene Corporation: Key Employees 11
Celgene Corporation: Key Employee Biographies 12
Celgene Corporation: Major Products and Services 17
Celgene Corporation: Company History 19
Celgene Corporation: Management Statement 26
Celgene Corporation: Locations and Subsidiaries 30
Celgene Corporation: Key Competitors 32
Celgene Corporation: Company Analysis 33
Celgene Corporation: Business Description 33
Celgene Corporation: SWOT Analysis 35
Celgene Corporation: SWOT Overview 35
Celgene Corporation: Strengths 35
Celgene Corporation: Weaknesses 36
Celgene Corporation: Opportunities 36
Celgene Corporation: Threats 38
Celgene Corporation: Corporate Financial Deals Activity 39
Celgene Corporation: Financial Deals Overview 39
Celgene Corporation: Targets and Partners 41
Celgene Corporation: Top Deals 2014 – 2018YTD* 45
Celgene Corporation: Advisors 46
Celgene Corporation: Top Legal Advisors 46
Celgene Corporation: Top Financial Advisors 46
Celgene Corporation: Mergers and Acquisitions 48
Celgene Corporation: Corporate Venturing 49
Celgene Corporation: Capital Raising 50
Celgene Corporation: Partnership 51
Celgene Corporation: Recent Developments 52
Celgene Corporation: News and Events Summary 52
Celgene Corporation: Business Expansion 56
Celgene Corporation: Corporate Governance 56
Celgene Corporation: Financial Performance 57
Celgene Corporation: Market Developments 57
Celgene Corporation: Regulatory and Legal Events 59
Celgene Corporation: Strategy and Operations 60
Appendix 61
Contact Us 61
Methodology 61
About MarketLine 62

List of Tables
Table 1: Celgene Corporation: Key Facts
Table 2: Celgene Corporation: Key Employees
Table 3: Celgene Corporation: Locations and Subsidiaries
Table 4: Celgene Corporation: Key Competitors
Table 5: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Celgene Corporation: M&A Activity by Geography (TTM*)
Table 7: Celgene Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Table 9: Celgene Corporation: Targets and Partners
Table 10: Celgene Corporation: Top Deals 2014 - 2018YTD*
Table 11: Celgene Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: Celgene Corporation: Financial Advisor Ranking by Value (US$m)
Table 13: Celgene Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Celgene Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Celgene Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Celgene Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Celgene Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Celgene Corporation: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Celgene Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Celgene Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Celgene Corporation: News and Events Summary
Table 22: Celgene Corporation: Business Expansion
Table 23: Celgene Corporation: Corporate Governance
Table 24: Celgene Corporation: Financial Performance
Table 25: Celgene Corporation: Market Developments
Table 26: Celgene Corporation: Regulatory and Legal Events
Table 27: Celgene Corporation: Strategy and Operations

List of Figures
Figure 1: Celgene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Celgene Corporation: M&A Activity by Geography (TTM*)
Figure 3: Celgene Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Celgene Corporation: M&A Average Deal Size - Value (US$m)
Figure 5: Celgene Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Celgene Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Celgene Corporation: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Celgene Corporation: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Celgene Corporation: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Celgene Corporation: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Celgene Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Celgene Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Celgene Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Diazyme Laboratories Inc:企業の製品パイプライン分析2018
    Summary Diazyme Laboratories Inc (Diazyme Laboratories) is a diagnostic reagents developer. The company offers test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. It offers products by markers, instrument specific packaging, po …
  • Cell Therapy Catapult Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cell Therapy Catapult Ltd (Catapult) is a provider of cell and gene therapy life cycle solutions. The company offers services such as industrialization, manufacturing, regulatory, health economics and market access, non-clinical safety and clinical operations. Its health economics and market …
  • Ajinomoto Co Inc (2802)-製薬・医療分野:企業M&A・提携分析
    Summary Ajinomoto Co Inc (Ajinomoto) is a food products company that focuses on foods, bioscience fine chemicals and pharmaceuticals and health. It carries out research and development and production of seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. The …
  • CiCi Enterprises, LP:企業の戦略・SWOT・財務情報
    CiCi Enterprises, LP - Strategy, SWOT and Corporate Finance Report Summary CiCi Enterprises, LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tokmanni Group Oyj (TOKMAN):企業の財務・戦略的SWOT分析
    Tokmanni Group Oyj (TOKMAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Brainsway Ltd (BWAY):企業の製品パイプライン分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Singapore Press Holdings Ltd (T39):企業の財務・戦略的SWOT分析
    Singapore Press Holdings Ltd (T39) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Reliance Infrastructure Ltd.:企業の戦略・SWOT・財務分析
    Reliance Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report Summary Reliance Infrastructure Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aratana Therapeutics Inc (PETX):企業の財務・戦略的SWOT分析
    Summary Aratana Therapeutics Inc (Aratana) is a provider of pet care solutions. The company develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. Its pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim …
  • 23andMe Inc-製薬・医療分野:企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …
  • Hetero Drugs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • PT Lotte Chemical Titan Tbk:企業の戦略・SWOT・財務情報
    PT Lotte Chemical Titan Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Lotte Chemical Titan Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Jiangsu Expressway Co Ltd (600377):企業の財務・戦略的SWOT分析
    Summary Jiangsu Expressway Co Ltd (Jiangsu Expressway) is a highway development company that offers services in investment, construction, operation and management of toll expressways within Jiangsu province. The company offers services such as geographical services, service area development, express …
  • CoLucid Pharmaceuticals Inc (CLCD)-製薬・医療分野:企業M&A・提携分析
    Summary CoLucid Pharmaceuticals Inc (CoLucid) is a pharmaceutical company that conducts research and develops new therapies. CoLucid’s lead product candidate Lasmiditan (COL-144), is an oral tablet that penetrates the central nervous system and selectively targets 5-HT1F receptors expressed in the t …
  • Veran Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Veran Medical Technologies Inc (Veran) is a medical device company that develops products for minimally invasive delivery of interventional oncology therapies. The company provides endobronchial products such as SpiN thoracic navigation system, Always-On tip tracked instruments, SpiNPerc and …
  • Addvalue Technologies Limited (A31):企業の財務・戦略的SWOT分析
    Addvalue Technologies Limited (A31) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • High Peak Royalties Ltd (HPR):石油・ガス:M&Aディール及び事業提携情報
    Summary High Peak Royalties Limited (High Peak) is a leading utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The compa …
  • Aon Plc:企業の戦略・SWOT・財務分析
    Aon Plc - Strategy, SWOT and Corporate Finance Report Summary Aon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Hoteli Maestral d.d.:企業の戦略・SWOT・財務情報
    Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report Summary Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CME Group Inc:企業のM&A・事業提携・投資動向
    CME Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CME Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆